Summary by Moomoo AI
China Biopharmaceuticals Limited (“China Biopharmaceuticals”) announced on 28 March 2024 that it will pay an ordinary dividend of HK$0.03 per share by the end of 2023. The dividend will be determined at the end of the fiscal year on December 31, 2023. The shareholder approval date is set for June 5, 2024 and the dividend distribution date is July 5, 2024. Share transfer registration will be suspended from 13 June to 18 June 2024 in order to process the distribution of dividends. The record date will be 18 June 2024. The net divisor is set on June 11, 2024. The Company's Board of Directors consists of seven executive directors and five independent non-executive directors.